Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 81,567 | 73,890 | 69,443 | 69,113 | 25,591 |
| Gross Profit | 81,567 | 73,890 | 69,443 | 69,113 | 50,110 |
| Operating Expenses | 34,876 | 36,171 | 36,950 | 36,725 | -25,770 |
| Operating Income | 46,691 | 37,719 | 32,493 | 32,388 | 51,361 |
| Interest Expense | 12,169 | 15,420 | 15,702 | 18,274 | 9,013 |
| Other Income | -1,803 | -3,100 | -335 | -246 | 224 |
| Pre-tax Income | 32,719 | 19,199 | 16,456 | 13,868 | 42,572 |
| Income Tax | -2,000 | 1,697 | 904 | 1,199 | 7,371 |
| Net Income Continuous | 34,719 | 17,502 | 15,552 | 12,669 | 35,201 |
| Net Income Discontinuous | -20,473 | -2,059 | -16,178 | -13,999 | -22,479 |
| Net Income | $14,246 | $15,443 | $-626 | $-1,330 | $12,722 |
| EPS Basic Total Ops | 0.69 | 0.75 | -0.16 | -0.20 | 0.64 |
| EPS Basic Continuous Ops | 1.85 | 0.87 | 0.76 | 0.60 | 1.78 |
| EPS Basic Discontinuous Ops | -1.16 | -0.12 | -0.92 | -0.80 | -1.26 |
| EPS Diluted Total Ops | 0.67 | 0.75 | -0.16 | -0.20 | 0.64 |
| EPS Diluted Continuous Ops | 1.82 | 0.86 | 0.76 | 0.59 | 1.77 |
| EPS Diluted Discontinuous Ops | -1.15 | -0.11 | -0.92 | -0.79 | -1.24 |
| EPS Diluted Before Non-Recurring Items | 1.76 | 1.04 | 0.78 | 0.67 | 0.54 |
| EBITDA(a) | $77,787 | $70,388 | $60,666 | $60,540 | $74,166 |